🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of this study is to evaluate efficacy and safety of Dextenza fo...
Status
Completed
Location
Retina Vitreous Surgeons of Central New York, PC
Start Date
2020-01-03
Trial ID
NCT04462523
Treatments Being Tested
Establishment of safety profile of HuMax-CD38 when given as monotherapy in ...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-26
Trial ID
NCT00574288
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
The aim of this study is to evaluate the efficacy of tumescent solution on ...
Status
Completed
Location
Pgids Rohtak
Start Date
2025-03-23
Trial ID
NCT07436546
This study will test how effective the drug, Carfilzomib, reduces progressi...
Status
Completed
Location
Birmingham VA Medical Center
Start Date
2014-04
Trial ID
NCT02047253
Treatments Being Tested
This research study is evaluating a new drug called "nivolumab" as a possib...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2016-10-20
Trial ID
NCT02903381
Treatments Being Tested
This prospective, randomized controlled study aims to evaluate the efficacy...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2026-04-07
Trial ID
NCT07515027
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
St. Mary's/Duluth Clinic Health System
Start Date
1995-06-02
Trial ID
NCT00002678
Treatments Being Tested
To find the recommended dose of the drug paclitaxel that can be given intra...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-01-30
Trial ID
NCT06207305
Treatments Being Tested